Clinical Practice Guideline: Tonsillectomy in Children
Leadership: Reginald Baugh, MD (Chair); Sanford Archer, MD (Assistant Chair); Ron Mitchell, MD (Assistant Chair); Richard M. Rosenfeld, MD, MPH (Methodologist)
Guideline Development Group: Raouf Amin, MD; James Burns, MD; David Darrow, MD, DDS; Terri Giordano, MSN; Ronald Litman, DO; Kasey Li, MD, DDS; Mary Ellen Mannix, MRPE; Richard H. Schwartz, MD; Gavin Setzen, MD; Ellen R. Wald, MD; Eric Wall, MD, MPH; Gemma Sandberg, MA
This guideline was published as a supplement in the January 2011 issue of Otolaryngology—Head and Neck Surgery.
This guideline is intended for all clinicians in any setting who interact with children aged 1 to 18 years who may be candidates for tonsillectomy. The guideline does not apply to tonsillotomy, intracapsular surgery, or other partial removal techniques of the tonsil because of the relatively sparse high-quality published evidence on these techniques and limited long-term follow-up. Similarly, the guideline does not apply to populations of children excluded from most tonsillectomy research studies, including those with diabetes mellitus, cardiopulmonary disease, craniofacial disorders, congenital anomalies of the head and neck region, sickle cell disease, and other coagulopathies or immunodeficiency disorders.
- Published Guideline
- Executive Summary
- Slideset available: contact Leslie Caspersen email@example.com for more information
- FDA Drug Safety Communication: Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death
- Research Gaps
- View/Order Guideline Pocket Card and Mobile App